Duramesh Use Grows Globally in 2025

As 2025 comes to a close, we reflect on a year of meaningful growth for Mesh Suture, Inc. and our flagship product, Duramesh. 

In 2025, Mesh Suture continued to expand significantly in both new and existing hospital systems across the US. We also grew our internal team to support increasing demand for Duramesh. 

From expanding into new countries and US cities, to welcoming new team members, supporting additional facilities, and connecting with surgeons at conferences across the globe—this year was about momentum. 
 
Most importantly, 2025 was about earning trust in the Operating Room and redefining the standard for surgical closure. 

2025 Highlights:

• Growing sales around the world : In 2025, we shipped more than 17,300 Duramesh units, representing a 63% year-over-year increase. This included distribution to 11 countries and 138 cities in 39 US states, including launching in Idaho and West Virginia in December. Throughout the year, 126 US facilities re-ordered, and 78 other US facilities ordered for the first time, reflecting strong interest in the product for new and existing hospitals.
• Our team is growing fast : We welcomed 7 new MSi team members across sales, marketing, and engineering, strengthening our ability to support surgeons and healthcare facilities.
• The word is spreading: We participated in 15 conferences and workshops from California and Tennessee to France and Peru.
• The results are clear : Two major sets of clinical data were released in 2025. A registry of 1,111 cases at Northwestern revealed encouraging outcomes, while an independent study led by Dr. Eric Pauli of Penn State and others demonstrated promising and substantiating positive short-term results with Duramesh.

Above all, Mesh Suture continued to earn trust in the operating room as we work to redefine the standard for surgical closure. 

We are grateful for the surgeon colleagues, partners, and team members who have joined us on this journey and look forward to continued growth and learning in 2026.